The main objective is to highlight the business activities of Kiril & Georgi Domuschiev in the US & Europe. The focus is on Huvepharma, one of the largest animal pharmaceutical companies in the US. This is a direct result of their FDI into the US over 20 years ago. It's the largest foreign investment into the US from Bulgaria. We are raising awareness in the US Congress, the State Department, Commerce and other US Government agencies about the strategic importance for the US of Huvepharma.
2026 · 2nd Quarter (Apr 1 - June 30)
KIRIL DOMUSCHIEV AND GEORGI DOMUSCHIEF
Filed by WASHINGTON GLOBAL ADVISORS LLC.
Open official filingSource-reported fields
Filing overview
- Type
- 2nd Quarter - Report
- Posted
- Aug 14, 2026
- Income
- Not reported
- Expenses
- Not reported
- Registrant
- WASHINGTON GLOBAL ADVISORS LLC
- Filing UUID
- e6a6bf5d-0fe6-4f21-83c7-9acf67f76d5a
- Termination date
- Not reported
Literal source text
Lobbying issues and bill citations
Relationship and amount limits
Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.